Molecular basis of cancer diathesis
Molecular basis of cancer diathesis
批准号:
14032201
负责人:
OKADA Masato
金额:
$60.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
为了开发新的策略来抑制癌症发生和控制癌症进展,在分子水平上理解原癌基因和抑癌基因产物的基本作用和调控特征是至关重要的。在这项研究中,我们广泛分析了src家族的原癌基因产物(SFK)的正常功能和调节,以了解SFK在癌症进展中所起的作用,特别是在转移活性的获得中。对缺乏Csk(SFK的负调节剂)的上皮癌细胞和突变小鼠的研究表明,SFK在细胞迁移和调节上皮样细胞向间质样细胞转变(EMT)中起关键作用。还发现SFK参与维持细胞极性所需的细胞-细胞粘附,并通过控制细胞骨架组织来调节细胞增殖。肌动蛋白结合蛋白Corpine及其相关分子 ...更多信息 在上皮样细胞向间质样细胞的转化中,细胞被鉴定为SFK的潜在靶点。此外,Csk作为这些现象的关键调节剂,这表明Csk可用作控制癌症进展和/或转移的潜在治疗靶点。2.在脂筏部分,提供了一个平台SFK信号,我们确定了一种新的膜磷蛋白Cbp(Csk结合蛋白)作为SFK的初始目标,并表明它作为膜支架蛋白Csk。3.为了分析SFK在动物中的基本作用,我们在C.优雅突变蠕虫的分析表明,SRC-1,Src的直向同源物,在器官发生过程中控制特定细胞类型的迁移中起着至关重要的作用。Rac信号通路被鉴定为SRC-1的下游靶标。4.基于Csk晶体结构提供的结构信息,我们提出了Csk调控SFK的分子基础。少
英文摘要
To develop new strategies to suppress carcinogenesis and to control cancer progression, it is critical to understand the fundamental roles and regulatory features of proto-oncogene and anti-oncogene products at the molecular level. In this study, we extensively analyzed the normal functions and regulation of the src family of proto-oncogene products (SFK) in order to understand the role played by SFK in cancer progression, and particularly in the acquisition of metastatic activity.1. Studies of epithelial cancer cells and mutant mice that lack Csk, a negative regulator of SFK, revealed that SFK plays critical roles in cell migration and in the regulation of the epithelial-like cell to mesencymal-like cell transition (EMT). It was also found that SFK is involved in the cell-cell adhesion required for the maintenance of cell polarity and for the regulation of cell proliferation through the control of cytoskeletal organization. Cortactin, an actin binding protein, and its associated molec … More ules were identified as potential targets of SFK in the epithelial-like cell to mesencymal-like cell transition. Furthermore, Csk acted as the critical regulator of these phenomena, suggesting that Csk could be used as a potential therapeutic target to control cancer progression and/or metastasis. 2. In the lipid raft fraction that provides a platform for SFK signaling, we identified a novel membrane phosphoprotein Cbp (Csk binding protein) as an initial target of SFK, and showed that it serves as a membrane scaffold protein for Csk. 3. To analyze the fundamental roles of SFK in animals, we identified SFK and Csk orthologues in C. elegans. Analysis of mutant worms revealed that SRC-1, an orthologue of Src, plays an essential role in controlling the migration of specific cell types during organogenesis. The Rac signaling pathway was identified as a downstream target of SRC-1. 4. Based on the structural information provided by the crystal structure of Csk, we proposed a molecular basis for SFK regulation by Csk. Less
期刊论文(67)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shimizu, K.: "SCOP, a novel binding partner of K-Ras in the membrane rafts, negatively regulates MAPK pathway"J. Biol. Chem.. (in press). (2003)
Shimizu, K.:“SCOP 是膜筏中 K-Ras 的一种新型结合伴侣,对 MAPK 通路具有负调节作用”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Rengifo-Cam W.: "Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells-implication for a potential role in cancer metastasis"Oncogene. 23. 289-297 (2004)
Rengifo-Cam W.:“Csk 定义了人类结肠癌细胞中整合素介导的细胞粘附和迁移的能力 - 暗示在癌症转移中的潜在作用”Oncogene。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1083/jcb.200401093
发表时间:
2004-08-02
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Fukuhara T, Shimizu K, Kawakatsu T, Fukuyama T, Minami Y, Honda T, Hoshino T, Yamada T, Ogita H, Okada M, Takai Y]
通讯作者:
Takai Y
Gu J.: "Csk regulates integrin-mediated signals : involvement of differential activation of ERK and Akt"Biochem Biophys Res Commun.. 303. 973-977 (2003)
Gu J.:“Csk 调节整合素介导的信号:参与 ERK 和 Akt 的差异激活”Biochem Biophys Res Commun.. 303. 973-977 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1016/s0014-5793(02)03819-x
发表时间:
2003-01-16
期刊:
FEBS LETTERS
影响因子:
3.5
作者:
[Hirose, T, Koga, M, Okada, M]
通讯作者:
Okada, M
共 22 条
Bayesian theory for spectral deconvolution and its expansion
-
批准号:24654118
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.25万
-
财政年份:2012
-
负责人:OKADA Masato
-
依托单位:
Probabilistic model for non-photorealistic image based on view point and its application to computer graphics
-
批准号:22650041
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.05万
-
财政年份:2010
-
负责人:OKADA Masato
-
依托单位:
Regulation of tumor growth via intracellular membrane compartments
-
批准号:22240088
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.12万
-
财政年份:2010
-
负责人:OKADA Masato
-
依托单位:
Visualization of a picture for information science and computer science
-
批准号:20240020
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.28万
-
财政年份:2008
-
负责人:OKADA Masato
-
依托单位:
Roles of tyrosine kinases during evolution of multicellular animals
-
批准号:19370053
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2007
-
负责人:OKADA Masato
-
依托单位:
Estimations of neural networks by fluctuations of neuron spikes
-
批准号:18079003
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$41.54万
-
财政年份:2006
-
负责人:OKADA Masato
-
依托单位:
The Molecular basis of tyrosine kinase signaling
-
批准号:17012015
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$87.62万
-
财政年份:2005
-
负责人:OKADA Masato
-
依托单位:
Role of tyrosine kinase in the evolution of multicellular animals
-
批准号:17370048
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2005
-
负责人:OKADA Masato
-
依托单位:
Discrete and continuous compressed information representation using phase transition phenomena
-
批准号:16500093
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.44万
-
财政年份:2004
-
负责人:OKADA Masato
-
依托单位:
Role of tyrosine kinase in the evolution of multicellular animals
-
批准号:15370056
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.73万
-
财政年份:2003
-
负责人:OKADA Masato
-
依托单位:
Statistical theory for Gaussian process function approximation based on theory of image restoration and its application
-
批准号:14580438
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2002
-
负责人:OKADA Masato
-
依托单位:
Statistical mechanics of relaxation process for Bayesian inference and its application
-
批准号:14084212
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$19.46万
-
财政年份:2002
-
负责人:OKADA Masato
-
依托单位:
Structural biology of tyrosine kinese signaling
-
批准号:13480208
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.6万
-
财政年份:2001
-
负责人:OKADA Masato
-
依托单位:
Functional analysis of cell cycle-related protein kinase in terminally differentiated neurons
-
批准号:10480169
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1998
-
负责人:OKADA Masato
-
依托单位:
Analysis of protein-tyrosine phosphatases involved in positive regulation of Src family protein-tyrosine kinases
-
批准号:06680612
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:OKADA Masato
-
依托单位:
国内基金
海外基金
登录
查看更多内容
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
-
批准号:82371223
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:闻大翔
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
-
批准号:82372089
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李万万
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
-
批准号:82372724
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:何竑超
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
EGFR通过激活β-catenin重塑肿瘤微环境代谢调控肿瘤免疫逃逸的分子机制研究
-
批准号:32100574
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邵飞
-
依托单位:
脯氨酸羟化酶EglN1转位到线粒体介导乳腺癌细胞适应缺氧应激的机制研究
-
批准号:32100570
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:闫朝君
-
依托单位: